Latin America Blood Testing Market

Latin America Blood Testing Market Size (2024 to 2029)

The size of the Latin America Blood Testing Market has been calculated at USD 5.88 billion in 2024. It is further expected to be growing at a CAGR of 2.79% and worth USD 6.75 billion by 2029.

Blood plays a distinctive role in life-saving, but can also be an impending vector for infectious diseases and at times proves to be lethal. With the rising prevalence of diseases, blood is a key biological sample for diagnostic techniques across the globe. Thus, blood testing is significant for diagnostics, in surgeries and for transfusion processes.

The market for blood testing continued to grow under the influence of aging population, rise in incidences of various diseases such as hepatitis, human immunodeficiency virus (HIV) infection, cancer, thyroids, genetic disorders and bacterial and viral allergic disorders, and expanding application of blood testing in other diagnostic areas.

This research report on the Latin America Blood Testing Market has been segmented and sub-segmented into the following categories.

Latin America Blood Testing Market Analysis By Type

• Complete Blood Count
• Blood Chemistry Tests
• Blood Enzymes Tests
• Blood Clotting Tests

Latin America Blood Testing Market Analysis By Disease

• Anemia
• Infection
• Leukemia
• Hypokalemia
• Kidney Disorders
• Heart Attack
• Coronary Heart Disease

Latin America Blood Testing Market Analysis By Method

• Manual Blood Culture Testing
• Automated Blood Culture Testing

Latin America Blood Testing Market Analysis By Country

• Brazil
• Mexico
• Argentina
• Chile
• Rest of Latin America

On the basis of region, Mexico is dominating the market and expected to continue its dominance over the forecast period.

Noteworthy companies dominating the Latin America Blood Testing Market profiled in the report are Bio-Rad Laboratories Inc. (U.S.), Siemens Healthcare (Germany), Grifols (Spain), Nanosphere Inc. (U.S.), BioMérieux (France), Dickinson and Company (U.S.), Ortho Clinical Diagnostics Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.) and Beckman Coulter (U.S.).